rilmenidine has been researched along with halothane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y; Kamibayashi, T; Mammoto, T; Takada, K; Yamatodani, A; Yoshiya, I | 2 |
| Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T; Yamanaka, H; Yamatodani, A | 1 |
3 other study(ies) available for rilmenidine and halothane
| Article | Year |
|---|---|
Rilmenidine prevents epinephrine-induced arrhythmias in halothane-anesthetized dogs.
Topics: Adrenergic alpha-Agonists; Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Halothane; Imidazoline Receptors; Male; Oxazoles; Receptors, Drug; Rilmenidine | 1995 |
Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Anesthetics, Inhalation; Animals; Arrhythmias, Cardiac; Blood Pressure; Dogs; Epinephrine; Female; Halothane; Heart Rate; Idazoxan; Imidazoline Receptors; Male; Oxazoles; Receptors, Drug; Rilmenidine; Yohimbine | 1996 |
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine.
Topics: Androstadienes; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; Halothane; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxazoles; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Rilmenidine; Signal Transduction; Sympathomimetics; Wortmannin | 2010 |